Eclipse Micro Pen Eclipse PRP
Call Toll Free 1-800-759-6876 CONTACT US

Eclipse’s Rapid Growth Leads to New Management

DALLASFeb. 6, 2018 /PRNewswire/ — Eclipse a leading global manufacturer and distributor of medical technology is proud to announce the promotion of Michael O’Brien to the position of Vice President of Sales for the United States. Over the last decade Michael has propelled his career as a successful sales representative, regional sales director, national sales director and now VP of Sales. Michael has been instrumental in transforming Eclipse from its origins as an aesthetic laser distributor into the trusted leader in Platelet Rich Plasma with the launch of Eclipse PRP.

In 2017 Eclipse grew substantially in size achieving record sales revenue under Michael’s leadership. He will now be focusing on the launch of eVIVE, a game changer for Men’s Wellness as well as the continued success of the entire Eclipse portfolio of products.

Eclipse is also very pleased to announce the promotion of Justin Parchman to Director of Sales for the United States. Justin has been a top contributor to Eclipse’s success over the past decade. Justin began his career at Eclipse in 2008 and has earned commendations as a top salesman, regional manager and now Director of Sales. “Justin has commanded the respect of the entire organization by executing at a very high level in every role he has been asked to perform,” says CEO and Founder Tom O’Brien.

“Both Michael O’Brien and Justin Parchman have become corporate role models by leading by word and deed. Watching the maturation and development of these men over the past decade at Eclipse has been such a pleasure to witness. They are both men of great work ethic and much integrity. Eclipse looks forward to reaching the next level with organic growth thanks to our phenomenal products and the leadership team that is guiding the company,” says O’Brien Read More


Eclipse Turns 25
DALLAS, Jan. 29, 2018 /PRNewswire/ — Only yesterday it seems that Tom O’Brien CEO/Cofounder and brother Paul O’Brien COO/CFO started Eclipse. In January 1993, the company began by shipping surgical products to hospital customers out of Tom’s garage in Dallas Texas. As a fledgling regional startup medical specialty distributor, Eclipse has evolved into the most successful privately held distributor and now manufacturer of aesthetic supplies in North America. From those humble early days Eclipse has grown into a multimillion dollar sales engine with leading best in class products which are sold through a talented U.S. direct sales force and a group of successful independent sales agents. In 2017 Eclipse doubled sales in the United States over previous year to date. As the company moves into 2018 Eclipse is now expanding sales worldwide!  

“As we reflect on the many milestones, successes and challenges, the fact remains that Eclipse exists to help our customers evolve their businesses and medical practices with innovative and affordable products which contribute to positive patient outcomes,” says Tom O’Brien. “We are grateful for the many thousands of loyal Eclipse customers. As we move into 2018 the future seems very bright as Eclipse prepares to launch several new product offerings which will help our customers further evolve their practices. We are honored to have been able to serve the market for this many years as we continue to grow with our many loyal customers in the years ahead,” says Tom O’Brien. To those customers attending the AAD conference in San Diego come by booth 1847 and help us celebrate the next 25 years. “We are not anything without our customer’s loyalty! For that loyalty, we a very grateful,” says Tom O’Brien.  Read More


Eclipse Aesthetics to Vigorously Defend Loyal Customer Base After RegenLab Threatens Suit of EclipsePRP Customers
DALLASDec. 18, 2017 /PRNewswire/ — RegenLab recently issued a press release announcing its new patent on their PRP kits, and threatened to sue even more Eclipse PRP customers.  “Not so fast,” says Tom O’Brien, CEO of Eclipse Aesthetics, LLC, “as we will show in court: we have strong defenses against this most recent so-called patent of Regen, not only in the US but worldwide. Eclipse and manufacturer Estar Medical pledge to step-in and defend Eclipse PRP customers sued or threatened to be sued by RegenLab’s campaign of harassment.”
As the undisputed US sales leader in PRP systems that use a proprietary and patented separation technology, Eclipse continues to be committed to supporting our customers just as we have for the last 25 years. As Eclipse and Estar continue working towards defeating the ill-conceived Regen tactics in the US courts, expect to continue receiving all the customer support with Eclipse PRP and its complete line of products. Eclipse stands by its loyal customers and its “best in class” products.  When a manufacturer sues a physician, for whatever reason, it hurts all stakeholders – industry, physicians and patients!  Please contact the Eclipse customer care hotline at (800) 759-6876 for any support that is needed! Read More
Theradome® Wins Best Hair Restoration Device Eclipse Aesthetics Garners THE Aesthetic Guide’s Aesthetic Industry Award for 2017
DALLASDec. 7, 2017 /PRNewswire/ — Eclipse Aesthetics, LLC is proud to announce the company’s top-selling Theradome® has garnered a prestigious award from THE Aesthetic Guide®. The Theradome has been honored with THE Aesthetic Industry Award in 2017 for Best Hair Restoration Device.
THE Aesthetic Guide is honoring those companies that have developed pioneering products and technologies in medical aesthetics via THE Aesthetic Industry Awards™,” per the popular industry publication. “Celebrating a field that continues to push the envelope with state-of-the-art innovations, winners were chosen by an esteemed panel of judges in a wide range of treatment categories.” The Theradome® distributed by Eclipse offers the world’s most advanced technology for hair restoration that can even be utilized from the comfort of one’s own home. This is not like Light Emitting Diodes (LED) devices. Theradome’s laser light targets the stem cells at the base of hair follicles. This action allows the formation of a new photonic pathway that can restore hair to a healthy state. The advanced, proprietary laser technology delivers maximum energy (> 440 joules per treatment) and penetrates the scalp at a wavelength optimized for clinical hair restoration (678 ± 8 nm). With its 80 high-efficiency lasers, it delivers therapeutic power while providing a maximum scalp coverage of 582 cm² and generating less than 1° C of heat per a 20-minute session (used twice a week). “Being selected as the best hair restoration device for 2017 is a great honor,” said Tom O’Brien, CEO and Founder of Eclipse Aesthetics. “The Theradome® popularity, reliability and clinical efficacy has proven to be a standard of care for many of our customers.” “We look forward to bringing many new offerings to market,” Mr. O’Brien added. “We are confident these products shall advance hair restoration to the next level in the days ahead.” Read More

Eclipse Aesthetics Wins Multiple Prestigious Aesthetic Everything® Diamond Crystal Awards Industry leader garners top honors for aesthetics, skin-care and hair restoration devices
DALLASSept. 25, 2017 /PRNewswire/ — Eclipse Aesthetics, LLC, a leader in aesthetics and medical supplies, is proud to announce the company has been recognized with three prestigious 2017 Aesthetic Everything® Diamond Crystal Awards including:

Top Aesthetics Companies Top Skin Care Devices Top Hair Restoration Devices

Industry award winners were selected by Aesthetic Everything® from over 10,000 votes cast on the aesthetic promoter’s website. The awards recognize companies and providers based on peer and customer nominations.

“Eclipse is truly honored to be the recipient of so many prominent awards,” said Tom O’Brien, CEO and Founder of Eclipse Aesthetics. “It is a privilege to be listed as a recipient along side some of the most prominent physicians, practices, companies and aesthetic leaders in our industry.” For 25 years, Eclipse has earned a reputation for providing superior solutions to the U.S. aesthetic and medical communities and has rapidly become a leader in the international aesthetic markets. Thousands of medical and skin-care professionals utilize Eclipse products in their practice in the United States and across the globe. The company has a portfolio of top-selling products including: Theradome®, laser helmet for hair regrowth; the award-winning Eclipse MicroPen® Elite*, micro-needling technology; dEp Patch™, micro-current mask and patches; and Crazy Cool® Hydro-Thermal Mask, among others. “Eclipse is excited about our latest product offering coming soon to the aesthetic marketplace,” Mr. O’Brien said. “The MicroPen® EVO** is the highly anticipated evolution of the Eclipse MicroPen® Elite. The all-new cordless dermal micro-needling device will retain all the features of its predecessor, but will also offer new capabilities never before available in a portable micro-needling pen.” With the simple change of a cartridge, users will have the option of selecting mechanical micro-needling, RF-based micro-needling or non-ablative bulk heating. Eclipse also provides medical supply and devices, such as Eclipse PRP™, platelet-rich plasma kits; and the all-new Eclipse eVIVE. “We look forward to bringing many new offerings to market,” Mr. O’Brien said. “We are confident these products will help advance practice offerings and patient results to the next level.” Read More

Regen Lab Admits Eclipse PRP Kit Does Not Infringe RegenLab Patent DALLASSept. 12, 2017 /PRNewswire/ — In May 2014, RegenLab, SA (“RegenLab”) published an email alleging that the Eclipse PRP kit contained pyrogens. Eclipse Aesthetics LLC (“Eclipse”), which distributes PRP Kits to a large number of medical providers throughout the United States, sent RegenLab a Cease & Desist Letter demanding that RegenLab issue a public retraction of the false email, pay an amount to cover Eclipse’s costs associated with a corrective advertising campaign, and make a $50,000 donation to the American Cancer Society as liquidated damages.
RegenLab failed to respond to the Eclipse Cease & Desist Letter and RegenLab did not make the requested donation to the American Cancer Society. In July 2014, Eclipse reluctantly brought a legal action against RegenLab for slander and defamation, among other claims (Case No. DC14-06990 (116th Judicial District Court in Dallas, Texas)) alleging that RegenLab intentionally made false statements in a marketing email stating that the Eclipse PRP kits contained pyrogen (contaminants) when in fact the Eclipse PRP kits do not contain pyrogen. Eclipse plans to introduce evidence during the litigation that will show that RegenLab fabricated the false information to intentionally damage Eclipse’s credibility in the marketplace. In November 2016, after the lawsuit against RegenLab had been pending for more than two years, RegenLab filed a lawsuit against Eclipse, a sub-distributor at the time, Healeon Medical Inc., and its PRP manufacturer, Estar Technologies, Ltd., for patent infringement (Case No. 16-cv-08771-ALC (SDNY)), claiming that the Eclipse PRP kit infringes its method patent. Then in May 2017, RegenLab sued three of Eclipse’s customers in New York (Case No. 1:17-cv-03845-UA (SDNY)) for allegedly infringing the same method patent by using the Eclipse PRP kit. In a press release published by RegenLab shortly after the lawsuit against Eclipse’s customers was filed, RegenLab alleges that the Eclipse PRP infringes the RegenLab ‘957 patent and that the customers somehow infringe upon that same patent by using the Eclipse PRP Kits. The press release mentions nothing about the requirements to infringe the method claim (Claim No. 20) that is asserted by RegenLab in both lawsuits. Eclipse filed counterclaims in the patent infringement suit alleging that the press release is misleading because the press release alleges that the Eclipse PRP kit infringes the patent when the product itself cannot infringe a method claim as a matter of law. In a recent order, Judge Carter found that the RegenLab “press release is easily misconstrued by those without significant patent law expertise” and that the “wording of the press release is confusing.” Judge Carter further found that “revisions to the press release would be useful to mitigate any potential confusion regarding the nature of the claims.” In a hearing in New York leading up to this Order, RegenLab’s counsel, Stephen Ball, admitted that the Eclipse PRP does not, in and of itself, infringe the RegenLab patent. RegenLab’s counsel went on to admit in his arguments to the court that “if they are using just the PRP without that last step of use in claim 20, then yes, I believe they would not be infringing.” Eclipse CEO, Tom O’Brien, was elated to hear that RegenLab admitted in court what he had known all along – that the Eclipse PRP does not infringe the RegenLab patent. Mr. O’Brien goes on to explain, “RegenLab has a utility patent pertaining to how PRP is mixed and used — their patent specifically requires the admixing of a cell extract after the creation of the PRP. Because the Eclipse PRP is a product, it cannot infringe upon RegenLab’s method patent. And even when the kit is used by doctors to create PRP, RegenLab’s counsel admits that those doctors do not infringe the asserted claim of the RegenLab patent if they do not admix any cell extracts with the PRP.” Eclipse and its manufacturer, Estar Technologies, Ltd. are currently defending the three Eclipse customers that Eclipse alleges RegenLab wrongly sued. Further, Eclipse has filed counterclaims against RegenLab for the false statements being made by RegenLab. Mr. O’Brien gives a warning to RegenLab representatives and others who are continuing to use the RegenLab press release to sway new customers, “you are warned — the continued use of the confusing press release will be met with swift action.” Read More

Eclipse Offers High Concentration PRP Tube in Canada

Additional clearance furthers Eclipse product growth of popular platelet-rich plasma kits

DALLASJune 26, 2017 /PRNewswire/ — Eclipse Aesthetics®, LLC., a leading aesthetic and medical manufacturer, announced it is expanding its Eclipse PRP® product line in Canada.

Recently, Health Canada cleared Eclipse PRP® (Health Canada Lic.#99292) products. The company is now offering Eclipse PRP® HC featuring a 22 mL high-concentration tube. The HC tube yields an average of ~11 mL of platelet-rich plasma. The Eclipse PRP® system is also available with the standard 11 mL tube that yields approximately ~6 mL of PRP.

Both tubes can be processed from the Eclipse Easy Spin™ Centrifuge (Health Canada Lic.#99293). Equipped with custom fit tube holders, the centrifuge offers PRP providers the flexibility to process 22 mL or 11 mL tubes from one unit.

Eclipse PRP® is an autologous system that allows for the safe preparation of pure PRP with optimal platelet recovery or 87% ± 10%. Virtually, all red blood cells (RBC) are eliminated from PRP for reduced inflammation. The concentration of pro-inflammatory Granulocytes (GRs) are also highly reduced. This system has been safely used in hundreds of thousands of procedures worldwide.

“Eclipse PRP® products are global best sellers. The system is fast, effective, simple to use, requires minimal steps, and allows for customizable concentration,” said Tom O’Brien, CEO and Founder of Eclipse. “Our company is pleased to now provide the 22 mL PRP kit along with the 11 mL PRP kit to practices in Canada though our distribution partner Salient Medical Solutions.”

“Both tubes offer an incredible value providing both quantity and quality,” said Jay Herman, President of Salient Medical Solutions. “Eclipse PRP® is an innovative system that is not only easy to use, it is available at a lower price per mL when compared to many other PRP kits on the market.”

Eclipse PRP® has been featured in U.S. and International media for its leading-edge cellular collection technology and remarkable results. Read more


Eclipse MicroPen® Elite Cleared by Health Canada

Regulatory clearance fuels global growth of award-winning micro-needling device

DALLASApril 26, 2017 /PRNewswire/ — Eclipse Aesthetics®, LLC., a leading aesthetic and medical manufacturer, is pleased to announce clearance by Health Canada for the the Eclipse MicroPen® Elite, an advanced medical-grade, automated, cordless, high-speed micro-needling device.

Clinics utilize the MicroPen® Elite to aid in the improved appearance of wrinkles, stretch marks, acne scars, skin tone and texture. The device can be used on various areas including the face, neck, décolleté, arms, hands and beyond.

“We’re excited to bring the Eclipse MicroPen® Elite to the Canadian market,” said Tom O’Brien, CEO and Founder of Eclipse. “The micro-needling pen’s popularity, reliability and clinical efficacy has been highly sought after by Canadian skin-care professionals at American medical conferences. For the first time, it can now be sold though our distribution partner Salient Medical Solutions.”

“Salient’s commitment to sourcing innovative and advanced medical technology continues with its alliance with Eclipse,” says Jay Herman, President of Salient Medical Solutions. “The micro-needling pen, company’s future innovations and commitment to regulatory compliance made our decision to partner with Eclipse clear.”

The automated micro-needling pen is a safe alternative to common skin resurfacing tools, such as lasers and dermal rollers. The MicroPen® Elite, which won THE Aesthetic Industry Award for “Best Micro-Needling Device,” is affordable, portable, effective, requires minimal to no down time and provides natural-looking results.

“With the Health Canada clearance and growing global distribution of Eclipse MicroPen® Elite, we look forward to reaching a new consumer base,” said Tom Goslau, Director of International Sales. “The device will allow skin-care providers a new and more effective way to address the evolving needs of aging consumers.” Read more


Eclipse Announces John Ohanesian as Strategic Advisor

Leading medical supply, aesthetic provider appoints former Bosley CEO to meet, enhance growth demands in domestic and international marketplace

DALLASMarch 3, 2017 /PRNewswire/ — Eclipse Aesthetics®, LLC., an award-winning manufacturer of medical and aesthetic supplies, is pleased to announce the addition of John Ohanesian, former CEO of Bosley®, as a key strategic advisor.

Mr. Ohanesian has an excellent reputation for transforming companies into worldwide success stories. During his 20-year tenure as the CEO of Bosley®, he grew the company into 90 markets. In his recent venture as the CEO of Cosmedica, LLC. and as a strategic advisor, Mr. Ohanesian has strategically helped companies develop markets in the retail medicine space with a focus on aesthetics, beauty and wellness.

“This is an exciting time of vast growth for our company,” said Tom O’Brien, Founder and CEO of Eclipse Aesthetics®, LLC. “Mr. Ohanesian is an excellent and integral addition to our ever-expanding company. This new role is a significant and exciting step forward as Eclipse continues to design, develop and market leading-edge products for the United StatesCanada and global market.”

“I am happy to be joining Eclipse, an outstanding distribution enterprise with a 25-year heritage,” said Mr. Ohanesian. “In my role as a strategic advisor, I foresee many opportunities in which my 27 years within the health, wellness and appearance medicine verticals will provide tremendous potential to further grow these sectors. In addition, we will identify and bring forth new and proven scientific-based products and technologies.”

“As a leader in the medical aesthetic industry, it’s essential to have proper personnel meet the company’s growth,” said Mr. O’Brien.  In addition, the Eclipse sales division is also expanding to meet the increasing demands of the supplier’s top-selling products, which includes: Eclipse PRP®, platelet-rich plasma kits; Eclipse MicroPen®, micro-needling device; Theradome™, hair-growth technology; dEp Patch™, micro-current patch and mask systems; and NEWA®, hand-held home-use RF device, among others.  Read more


Eclipse Launches NEWA®, Home-Use RF Skin-Care System

Leading Aesthetic Provider Exclusive U.S. Distributor to Skin-Care Professionals of First FDA-Cleared, Energy-Based Wrinkle-Reduction Device

DALLASDec. 7, 2016 /PRNewswire/ — Eclipse Aesthetics®, LLC., a leading aesthetic and medical supply company, proudly announces it has partnered with EndyMed Medical Ltd., a pioneer and leader in multi-source radiofrequency (RF) technology products, to offer the NEWA® through medical aesthetic professionals. The energy-based RF device is the first of its kind to receive FDA clearance for aesthetic home-use.

The NEWA®, a non-invasive skin-care system, is based on EndyMed’s patented 3DEEP® RF technology. The device is clinically proven to reduce mild to moderate facial wrinkles utilizing the revolutionary technology. NEWA® delivers controlled energy into the skin, which can aid in the reduction of fine lines and wrinkles.

The innovative system was developed by an internationally renowned dermatologist and received the Edison Innovation Award for 2013 in the Medical Scientific Category. NEWA® is an ideal complement to in-office treatment devices including Eclipse Firma™ and Eclipse Skinfinity RF™. The device enables consumers to safely enhance results in the comfort and convenience of their homes. Consumers can personalize their regimen with the NEWA® app, available for iPhone and Android users.

“Eclipse is very excited to be launching this ground-breaking technology in the United States,” said Tom O’Brien, CEO of Eclipse. “It’s a clinically proven system that eclipses other home-use devices. It empowers consumers to supplement and enhance the results of in-office procedures.” The award-winning device is now available from select dermatologists, plastic surgeons and medical spas. “The time for NEWA® is now,” he added.

“We’re pleased to partner with Eclipse to offer the first FDA-cleared RF device for home-use in the U.S.,” stated Amy Kamin, CEO of EndyMed USA. “This device is like no other available and will solidify our leading technological position in the world’s RF-based home-use devices market.”

Studies reveal skin loses 1-2% of its collagen annually after the age of 30. Over time, collagen loss can lead to wrinkles and older-looking skin. While some creams advertised for anti-aging may aid in the surface appearance, RF devices, such as NEWA®, work deep under the skin’s surface where wrinkles begin to form.

Eclipse Aesthetics®, LLC. provides solutions to the U.S. and International aesthetic and medical communities. Eclipse offers a portfolio of products including: Eclipse PRP®, platelet rich-plasma kits; Eclipse MicroPen®, micro-needling technology; and Eclipse Skinfinity RF™, among others. www.EclipseMed.com


Eclipse Aesthetics Expands Popular PRP Product Line

DALLAS, Aug. 18, 2016 /PRNewswire/ — Eclipse, a leading medical supply company, is enhancing and expanding the Eclipse PRP® product line to meet the growing needs of practices offering platelet-rich plasma procedures.

The company is introducing the all-new Eclipse PRP® HC kit featuring a 22 mL high-concentration tube. The new tube will yield an average of ~11 mLs of platelet-rich plasma. In addition,

the popular 10 mL tube has been increased to an 11 mL size that yields approximately ~6 mLs of PRP.

Also being released tandem with the PRP tubes, the company is offering the all-new Eclipse Easy Spin® Centrifuge. With multiple-size tube holders, the centrifuge offers flexibility for platelet-rich plasma providers who want to process the new, larger 22 mL or 11 mL tubes from one unit.

The Eclipse PRP® system is fast, effective, simple to use, requires minimal steps, and allows for customizable concentration. “The new Eclipse PRP® HC tube, larger standard tube and additional centrifuge will allow practices more options to meet the varying needs of their patients,” said Tom O’Brien, CEO and Founder of Eclipse. “Both tubes also offer an incredible value. You get both quantity and quality. Eclipse PRP is a lower price per mL when compared to many other PRP kits on the market.”

Eclipse PRP® is an autologous system that has been featured in national media. The easy-to-use, all-in-one kits allow physicians to prepare platelet-rich plasma. The PRP is optimally concentrated with the highest platelet yield of ~90%. These systems have been safely used in hundreds of thousands of procedures worldwide. Read more.


Eclipse Aesthetics® Partners to Offer Clearista® Pro Line

DALLASMarch 11, 2016 /PRNewswire/ — Eclipse Aesthetics®, LLC has formed a partnership with Skincential Sciences, a medical diagnostics company in southern California. Eclipse will serve as the exclusive distributor for ClearistaPRO™, specially formulated products to safely and effectively remove biomarkers from tissue. The innovative product line is featured on The Doctors TV show March 14, 2016.

“Eclipse is pleased to be distributing the professional Clearista® product line! The line is designed to improve the skin, soften and aid in removal of benign pigmented lesions with its proprietary refining pen and retexturing gel,” said Tom O’Brien, CEO and Founder of Eclipse Aesthetics®.

The ClearistaPRO® system is based on years of extensive research and clinical trials. In 2013, the company’s hard work resulted in a patent for a highly effective product that aids in the skin’s natural exfoliation process and reduces the appearance of rough patches, skin bumps (e.g. keratosis pilaris), surface blemishes and pigmented surface spots (e.g. seborrheic keratosis).

“We are delighted to be partnering with Eclipse Aesthetics® to bring the Clearista® brand to their customers,” Russ Lebovitz, Skincential Sciences CEO.  “Skincential Sciences is very proud of the proprietary nature of our Clearista® formula and the many resurfacing benefits it provides to all skin types. Eclipse Aesthetics has built a strong, reputable organization by bringing quality products to the market and we look forward to adding this strong product offering.” Read more.


Eclipse Aesthetics Announces Key Hires to Meet Company Growth

DALLAS, Oct. 27, 2015 /PRNewswire/ — Eclipse Aesthetics, LLC is pleased to announce the addition of key team members to the aesthetic supply company. The business is expanding to meet increasing demands due to new product development and sales growth.

Shawn Beddes joins the company as a Quality Assurance Manager. He’s integral to the team as Eclipse Aesthetics offers additional Food and Drug Administration (FDA) registered products. He has over 13 years of experience in the medical device and pharmaceutical manufacturing industries. “I look forward to working with Eclipse to help fast track our ISO 13485 certification as the company continues to rise to new heights,” he said.

Eclipse Aesthetics also welcomes Melanie Seagraves as a Quality Assurance Process Analyst overseeing the FDA and ISO Compliant Quality Systems.  She has a Bachelor’s of Science degree in Biology and experience working for a major medical device manufacturer. She’s well versed in handling non-conforming products, document control, records management and corrective actions.

–>”We’re excited to see our Quality Assurance Department and Eclipse Aesthetics’ team grow,” said Tom O’Brien, CEO of Eclipse Aesthetics. “As a leader in the aesthetic industry, it’s essential to have proper protocols and personnel. The Quality Assurance team makes certain all FDA regulations are met and every product meets the company’s best-in-class standards.” Read more.


Eclipse Aesthetics, LLC Files Suit Against RegenLab USA, LLC 

DALLASJuly 23, 2014 /PRNewswire/ — On Tuesday, July 1, 2014Eclipse Aesthetics, LLC (“Plaintiff”) filed suit in the 116th Judicial District Court in Dallas, Texas, against RegenLab USA, LLC (“Defendant”) for Tortious Interference with Current and Prospective Business Relationships through false and misleading actions, fraud, fraud-in-the-inducement, business interference, tortious interference; and, Business Disparagement through libel, disparagement, defamation, misrepresentation, and violating the false/deceptive advertising laws (among other laws) that are valid in every state in the United States.

Eclipse Aesthetics is a developer and supplier of aesthetic-based products for cosmetic procedures including Platelet Rich Plasma (Eclipse PRP™). RegenLab USA designs, develops, manufactures, and commercializes Platelet Rich Plasma (PRP) for professional markets.

As a result of RegenLab USA knowingly sending a false, fraudulent, and deceptive Promotional E-mail that was intentionally designed to disparage Eclipse and Eclipse PRP™ while damaging its standing within the medical care community, Eclipse has filed suit against RegenLab USA.

CONTACT: Info@eclipsemed.com, 800-759-6876

Read More.


Eclipse Aesthetics Launches NEW Safety Applicator For the Eclipse MicroPen™

Eclipse Aesthetics, LLC, makers of the popular Eclipse MicroPen® is excited to launch its new fluid resistant vented Application Tip. Featured on The Doctors, the new vented Turbo Safety Cartridge makes the Eclipse MicroPen™ the safest and most effective single use micro-needling system available. The Eclipse MicroPen® is a cutting-edge, surgical grade micro-needling device designed for the improvement of stretch marks, acne scars, fine lines and wrinkles.

The new Safety Applicator available exclusively by Eclipse Aesthetics provides significant advances in micro-needling technology:

  • Virtually eliminates cross-contamination risk by blocking migration of fluids through the  needle applicator housing
  • Vented port to reduce vacuum pressure which could contribute to the formation of broken capillaries
  • 12 sterile 32-gauge precision sharp surgical grade needles for rapid healing and minimized discomfort results

“Micro-needling is becoming more popular, due to its safe, predictable results. There are many brands of micro-needling devices available but the unique features of the Safety Applicator Tip are what separates the Eclipse MicroPen® from the other needling devices. The unique feature of the needle applicator with fluid barrier design reduces the risk of cross-contamination exponentially even as it oscillates back and forth at a very high rate of speed. Patient safety and efficacy is most important to me which is why the Eclipse MicroPen® is the only micro-needling device I feel comfortable using and delegating.”  – Tess Mauricio, MD Read more.


Leading Edge Laser Technology Comes To Zimmet Vein and Dermatology

Steven E. Zimmet, M.D. Director of Zimmet Vein and Dermatology of Austin, Texas announces the introduction of the first Tri-Beam Q-Switch laser system available in Texas. The Tri-Beam Q-Switched Nd:YAG laser is specially designed for tattoo removal, treatment of pigmented lesions, melasma, acne, and non-ablative skin rejuvenation. The Tri-Beam also delivers a means to improve skin tone and texture. Read more.


Announcing – Equinox CO2 fractional laser by Eclipse Aesthetics, LLC.

Equinox CO2 fractional laser is capable of aiding the physician to deliver consistent and dramatic, visible improvement to the patient in a single 30-minute treatment session.

Dallas, Texas, BUILT TO LAST AND TO PERFORM, Equinox CO2 fractional laser is capable of aiding the physician to deliver consistent and dramatic, visible improvement to the patient in a single 30-minute treatment session. Equinox is designed to effectively deliver superior skin resurfacing and rejuvenation results with excellent improvement of fine lines and wrinkles, acne, surgical scars, skin pigmentation or discoloration, sun damage, pre-cancerous and benign lesions.

Equinox boasts the flexibility of a fractional CO2 laser with enhanced ability to infinitely adjust the dot pitch or laser beam spacing providing simplicity and accuracy for outstanding patient results. Equinox is exclusively manufactured for Eclipse Aesthetics, LLC.


Smooth Cool HR/SR Light Based Hair Removal

Eclipse, the leading US national distributor of advanced medical and aesthetic devices, introduces Smooth Cool HR/SR, a world-class technology that’s proven to be a best in class player in the light based hair removal market. Read more.

Eclipse Aesthetics

5916 Stone Creek Dr. Suite #120
The Colony, TX 75056
United States

Call or fax us

Toll-free: 1-800-759-6876
Local: 1-972-380-2911
Fax: 1-866-558-0415

drop us a line

sales@eclipsemed.com

ECLIPSE THE COMPETITION © Eclipse Aesthetics, All rights reserved